Under the guidance of Professor Robert Dorit, Nancy conducted research that has far-reaching implications for those impacted by antibiotic resistance. She was working toward a goal of creating a more intelligently designed antibiotic that targets only a specified bacteria, preserving essential gut flora—and leaving patients healthier and less vulnerable to other infections.
